165 related articles for article (PubMed ID: 3842318)
1. Monoclonal antibody therapy of lymphoid malignancy.
Lowder JN; Meeker TC; Levy R
Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318
[TBL] [Abstract][Full Text] [Related]
2. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
Hatzubai A; Maloney DG; Levy R
J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
[TBL] [Abstract][Full Text] [Related]
3. Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.
Stevenson GT; Glennie MJ
Cancer Surv; 1985; 4(1):213-44. PubMed ID: 3916080
[TBL] [Abstract][Full Text] [Related]
4. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
[TBL] [Abstract][Full Text] [Related]
5. Differences in "host infiltrates" among lymphoma patients treated with anti-idiotype antibodies: correlation with treatment response.
Garcia CF; Lowder J; Meeker TC; Bindl J; Levy R; Warnke RA
J Immunol; 1985 Dec; 135(6):4252-60. PubMed ID: 2933460
[TBL] [Abstract][Full Text] [Related]
6. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
Schroff RW; Foon KA; Beatty SM; Oldham RK; Morgan AC
Cancer Res; 1985 Feb; 45(2):879-85. PubMed ID: 3871353
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
Kon S
Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
9. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma.
Basham TY; Kaminski MS; Kitamura K; Levy R; Merigan TC
J Immunol; 1986 Nov; 137(9):3019-24. PubMed ID: 3760580
[TBL] [Abstract][Full Text] [Related]
11. Anti-idiotypes in B-cell tumor therapy.
Miller RA; Lowder J; Meeker TC; Brown S; Levy R
NCI Monogr; 1987; (3):131-4. PubMed ID: 3493440
[TBL] [Abstract][Full Text] [Related]
12. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic lymphocytic leukaemia with monoclonal anti-idiotypic antibody.
Capel PJ; Preijers FW; Allebes WA; Haanen C
Neth J Med; 1985; 28(3):112-8. PubMed ID: 3982571
[No Abstract] [Full Text] [Related]
15. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
16. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
Foon KA
N Engl J Med; 1982 Sep; 307(11):686-7. PubMed ID: 6981064
[No Abstract] [Full Text] [Related]
17. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy in lymphoid leukemias.
Lin TS; Byrd JC
Adv Pharmacol; 2004; 51():127-67. PubMed ID: 15464908
[No Abstract] [Full Text] [Related]
19. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.
Dillman RO; Beauregard J; Shawler DL; Halpern SE; Markman M; Ryan KP; Baird SM; Clutter M
J Biol Response Mod; 1986 Oct; 5(5):394-410. PubMed ID: 3490543
[TBL] [Abstract][Full Text] [Related]
20. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
